Thanks I understand they can leverage the detail - just wondering if that alleviates the need for additional local trials?
Ann: Investor Presentation, 14 March 2023, page-13
-
- There are more pages in this discussion • 133 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.58 |
Change
0.060(0.29%) |
Mkt cap ! $2.622B | |||
| Open | High | Low | Value | Volume |
| $20.60 | $20.72 | $20.53 | $241.6K | 11.72K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 105 | $20.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.60 | 93 | 2 |
View Market Depth
| Last trade - 10.17am 15/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |